Sequential Skin
End-to-End Microbiome Testing Platform
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- sequentialskin.com
- Total Funding
- $5.2M
- Last Round
- $3.5M SeedMar 2026
About
Sequential Skin is a UK-Singapore biotech company offering a full end-to-end in vivo microbiome testing platform for the personal care industry. Its services cover skincare, scalp care, oral care, and intimate care product testing using genomic and microbiome analysis. The company pivoted from direct-to-consumer personalized skincare to a B2B testing platform serving cosmetic brands and researchers.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account